| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.41B | 14.03B | 13.34B | 9.64B | 9.06B | 10.14B |
| Gross Profit | 2.42B | 2.93B | 2.38B | 2.11B | 2.15B | 2.17B |
| EBITDA | 950.15M | 1.40B | 1.04B | 911.43M | 848.56M | 818.41M |
| Net Income | 458.74M | 736.03M | 536.29M | 456.10M | 406.74M | 394.04M |
Balance Sheet | ||||||
| Total Assets | 24.66B | 25.80B | 25.00B | 22.75B | 21.17B | 19.93B |
| Cash, Cash Equivalents and Short-Term Investments | 5.10B | 4.84B | 5.57B | 5.00B | 5.62B | 5.35B |
| Total Debt | 268.18M | 0.00 | 29.80M | 31.73M | 31.73M | 10.10M |
| Total Liabilities | 9.96B | 10.17B | 10.20B | 8.34B | 7.32B | 6.46B |
| Stockholders Equity | 14.70B | 15.63B | 14.80B | 14.42B | 13.85B | 13.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -136.80M | 1.16B | 261.84M | 677.43M | 645.28M |
| Operating Cash Flow | 0.00 | 414.18M | 1.59B | 1.10B | 1.18B | 892.58M |
| Investing Cash Flow | 0.00 | -682.80M | -6.56M | -2.25B | -777.75M | 667.89M |
| Financing Cash Flow | 0.00 | -353.10M | -207.35M | -172.11M | -132.48M | -118.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥70.93B | 12.85 | ― | 2.63% | 2.11% | 0.91% | |
74 Outperform | ¥20.44B | 27.79 | ― | 2.78% | 5.18% | 37.11% | |
70 Outperform | ¥61.72B | 12.68 | 11.47% | 1.88% | -0.81% | 28.73% | |
65 Neutral | ¥189.56B | 13.93 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥69.91B | 12.05 | ― | 3.09% | 7.43% | 47.68% | |
61 Neutral | ¥72.28B | 15.17 | ― | 0.55% | 2.93% | 10.00% |